The Chinese company was established in 1993. It is a management investment company, which is mainly engaged in pharmaceutical and health-care, commodity trading, real estate investment, and financial services business.
Currently, it is a comprehensive pharmaceutical company with wide therapeutic areas, rich product lines and advanced technology, providing hundreds of drugs and medicines, medical devices, active pharmaceutical ingredients (API), chemical intermediates, healthcare products and other related pharmaceutical products. Meantime, the company has a professional marketing system and a sales network all over the country. Multiple products have passed the European COS (Certificate of Suitability) certification and FDA (Food and Drug Administration) certification and have been exported to many countries and regions.
After more than 20 years of development, the Chinese company has formed a business model integrating R&D, production and sales. It develops traditional Chinese medicines, chemical medicines, biological medicines, medical devices as well as medical cosmetics, and jointly explores domestic and international markets.
For a long time, the Chinese company has been focused on the manufacturing, research and development of human medicine. Due to business needs and the adjustment of the company's development direction, the Chinese company expects to expand the pharmaceutical field to bio-pesticide and bio-fertiliser, looking for European bio-pesticide and fertiliser technologies via commercial agreement with technical assistance cooperation.